Medicenna Therapeutics

Developer of interleukin-4 Receptor (IL4R) targeted cytokines for cancer

placeHouston, Texas, United States calendar_todayFounded 2012 groups1 employees language medicenna.com

Registered entities

Innovation

16 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 2,827 times.

YearFilings
20152
20163
20172
20183
20195
20207
20218
20223
20237
20249
20257
20262

Social engagement

Social engagement: 4.5K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital125%
Accelerator & incubator125%
Other / undisclosed250%

Recent activity

26 Jun 2026
Milestone
regulatory
11 Jun 2026
Milestone
regulatory
3 Jun 2026
Milestone
regulatory
Coming soon